tweenvest

Crinetics Pharmaceuticals, Inc. (NasdaqGM: CRNX)

Health Care · Pharmaceuticals · US

$84.95

+0.13% today · +97.2% 1Y

Public summary
A free snapshot of Crinetics Pharmaceuticals, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Crinetics Pharmaceuticals, Inc. (NasdaqGM: CRNX) operates in the Pharmaceuticals industry within the Health Care sector.

Over the last twelve months the share price has gained 97.2%, trading between 32.30 and 85.01.

Tweenvest scores Crinetics Pharmaceuticals, Inc. across four factors: quality 38/100, value 88/100, growth 100/100. Its strongest factor is growth.

CRNX price history

Nov 21, 2025 · 42.86Weekly closes 32.92 – 84.95Aug 31, 2026 · 84.95

Key figures

Market cap
—
Revenue (TTM)
$42.16M
P/E
-17.96
EPS
-5.04
Dividend yield
—
Beta (5Y)
—
52-week high
$85.01
52-week low
$32.30
Avg volume (3M)
—
Shares outstanding
—
Employees
594
Next earnings
—

About Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.

ISIN
US22663K1079
Founded
2008
Listed since
Jul 18, 2018
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
The Greenrose Holding Company Inc.OTCPK: GNRS.Q$18.00$0.000.00%
Lowell Farms Inc.OTCPK: LOWL.F$18.00$0.000.00%
West Island Brands Inc.OTCPK: WIBF.F$17.00$0.000.00%
BioELife Corp.OTCPK: LITH$9.00$0.00-99.00%
Biostar Pharmaceuticals, Inc.OTCPK: BSPM$3.00$0.00-99.00%
Clever Leaves Holdings Inc.OTCPK: CLVR$2.00$0.00-99.90%
BC Craft Supply Co. Ltd.OTCPK: CRFT.F$2.00$0.000.00%
Seelos Therapeutics, Inc.OTCPK: SEEL.Q$1.00$0.000.00%

Browse every Pharmaceuticals company →